169269 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for cancer; Specifically defined cancers of ovaries
UHRF1 DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE
#602TTK DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE
#603Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
#604Regulators of the non-genomic action of progesterone and methods of use
#605Drug resistance and methods of reversing
#606Pro104 antibody compositions and methods of use
#607Antibody directed against PAP2a and use thereof for diagnostic and therapeutic purposes
#608Cytotoxicity mediation of cells evidencing surface expression of CD44
#609Anti-PDEF antibodies and uses thereof
#610Biomarkers for ovarian cancer
#611TLE3 as a marker for chemotherapy
#612JAB1 as a prognostic marker and a therapeutic target for human cancer
#613Uses of antileukoprotease in carcinoma
#614Novel compositions and methods for identification, assessment, prevention, and therapy of ovarian cancer
#615Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1)
#616STEM CELL TARGETING OF CANCER, METHODS AND COMPOSITIONS THEREFOR
#617Diagnosis of carcinomas
#618Tumor markers for ovarian cancer diagnosis
#619METHODS AND COMPOSITIONS FOR THE DETECTION OF OVARIAN DISEASE
#620METHODS FOR IDENTIFYING PATIENTS WITH AN INCREASED LIKELIHOOD OF HAVING OVARIAN CANCER AND COMPOSITIONS THEREFOR
#621Diagnostic serum antibody profiling
#622Diagnostic methods
#623Methods for evaluating the stage of ovarian cancer or the survival rate of an ovarian cancer patient
#624METHODS FOR IDENTIFYING PATIENTS WITH AN INCREASED LIKELIHOOD OF HAVING OVARIAN CANCER AND COMPOSITIONS THEREFOR
#625SLC9A3R1 DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE
#626Methods and compositions for detecting spermatozoa or semen in a sample
#627METHODS FOR DIAGNOSIS AND/OR PROGNOSIS OF OVARIAN CANCER
#628Neoplasia-Specific tNOX Isoforms and Methods
#629Cancer Antigen Mage-A9 and Uses Thereof
#630Diagnosis of Gynecological Neoplasms by Detecting the Levels of Oviduct-Specific Glycoprotein
#631Collagen VI and cancer
#632Methods for the early diagnosis of ovarian cancer
#633Predictive markers for ovarian cancer
#634Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
#635Predictive and therapeutic markers in ovarian cancer
#636Cancer Screening Test
#637Neoepitope detection of disease using protein arrays
#638Methods and Materials for Examining the P13k/Akt Pathway in Gliomas and Prostate Cancers
#639Methods and compositions for diagnosing neoplastic disease
#640Biomarkers for detecting cancer
#641Methods of detecting ovarian cancer
#642Monoclonal antibodies and uses thereof
#643Immunotherapeutic methods targeted toward stratum corneum chymotryptic enzyme
#644Methods for diagnosing ovarian cancer
#645Brca1 Markers
#646Targeting of Erb Antigens
#647PIK4CA as modifier of the Rac pathway and methods of use
#648METHOD OF TREATING DISEASES WITH PARP INHIBITORS
#649Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use
#650Methods for the Diagnosis of Colorectal Cancer and Ovarian Cancer by the Measurement of Vitamin E-Related Metabolites
#651HE4 monoclonal antibodies and methods for their use
#652Methods of diagnosing ovarian cancer and kits therefor
#653SPHKS as modifiers of the p53 pathway and methods of use
#654COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF OVARIAN CANCER
#655COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF OVARIAN CANCER
#656Compositions and methods for the therapy and diagnosis of ovarian cancer
#657Cytotoxicity mediation of cells evidencing surface expression of CD44
#658Protein markers for the diagnosis and prognosis of ovarian and breast cancer
#659Overexpression of mammaglobin B in ovarian and endometrial tumors - a new diagnostic and therapeutic marker
#660Method for diagnosing tumors
#661MARKs as Modifiers of the p53 Pathway and Methods of Use
#662Diagnostic and therapeutic methods based on the L1 adhesion molecule for ovarian and endometrial tumors
#663SHC proteins as therapeutic targets in proliferative diseases
#664METHODS AND COMPOSITIONS FOR DIAGNOSING NEOPLASTIC DISEASE
#665Methods for predicting preganancy outcome in a subject by hCG assay
#666SCDs As Modifiers of the p53 Pathway and Methods of Use
#667Diagnostics and Therapeutics for Diseases Associated with Protein Kinase, Cgmp-Dependent, Type I (Prkg1)
#668Diagnostic PKM2 methods and compositions
#669Cytotoxicity mediation of cells evidencing surface expression of CD63
#670Biomarkers for early detection of ovarian cancer
#671Method for detecting an inflammatory disease or cancer
#672HERV-K Antigens, Antibodies, and Methods
#673Detection of cancer by elevated levels of BCL-2
#674RSF-1 as a prognostic marker and therapeutic target
#675Biomarker isolation and use thereof to characterize physiological state
#676Method for Early Detection of Ovarian Cancer
#677DETECTION, PREVENTION AND TREATMENT OF OVARIAN CANCER
#678Diagnostics and Therapeutics for Diseases Associated with Tripeptidyl-Peptidase 2(Tpp2)
#679METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS
#680METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS
#681Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor
#682Methods for identification, assessment, prevention, and therapy of cancer
#683Method Of Therapy
#684Free NGAL as a biomarker for cancer
#685Method for detecting ovarian cancer
#686Novel compositions and methods for the identification, assessment, prevention, and therapy of human cancers
#687Cln101 antibody compositions and methods of use alone and in combination with prostate specific antigen and other cancer markers
#688Methods of diagnosis and prognosis of ovarian cancer II
#689Biomarker for ovarian cancer
#690Method for diagnosing selected adenocarcinomas
#691Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins
#692Methods of diagnosis of androgen-dependent prostate cancer, prostate cancer undergoing androgen withdrawal, and androgen-independent prostate cancer
#693HPRP4s modifiers of the p53 pathway and methods of use
#694Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
#695Composition, splice variants and methods relating to ovarian specific genes and proteins
#696Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
#697Loc169505 as modifiers of the apc and axin pathways and methods of use
#698Tumor marker for ovarian cancer diagnosis
#699Tissue diagnostics for ovarian cancer
#700Pro104 antibody compositions and methods of use
#701Alpha enolase-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance
#702Genes overexpressed by ovarian cancer and their use in developing novel therapeutics
#703Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 85 (gpr85)
#704Reagents and methods for use in cancer diagnosis, classification and therapy
#70526199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
#706Shc proteins as therapeutic targets in proliferative diseases
#707Biomarker for ovarian and endometrial cancer: hepcidin
#708Diagnostic marker for ovarian cancer
#709Cytotoxicity mediation of cells evidencing surface expression of CD44
#710Enhanced diagnostic multimarker serological profiling
#711Quantitative assays for PDGFR-beta in body fluids
#712Cancerous disease modifying antibodies
#713Cancerous disease modifying antibodies
#714Methods for predicting pregnancy outcome in a subject by hCG assay
#715Diagnosis of gynecological neoplasms by detecting the levels of oviduct-specific glycoprotein
#716Method for prognostic evaluation of carcinoma using anti-P-LAP antibody
#717DIAGNOSING AND TREATING CANCER
#71814094, a novel human trypsin family member and uses thereof
#719Interleukin-8 homologous polypeptides and therapeutic uses thereof
#720Methods for the identification, assessment, and treatment of patients with cancer therapy
#721Genes regulated in ovarian cancer a s prognostic and therapeutic targets
#722Pygopus in diagnosis and treatment of cancer
#723Sphks as modifiers of the p53 pathway and methods of use
#724G protein-coupled receptors
#725Methods for detecting endocrine cancer
#726Methods for diagnosing and treating tumors and suppressing cd promoters
#727Cytotoxicity mediation of cells evidencing surface expression of CD63
#728Methods for identifying tumors responsive to treatment with HER dimerization inhibitors (HDIs)
#729Interleukin-8 homologous polypeptides and therapeutic uses thereof
#730LIMKs as modifiers of p53 pathway and methods of use
#731Composition splice variants and methods relating to cancer specific genes and proteins
#732Methods for detecting endocrine cancer
#733Tubulin isotype screening in cancer therapy using hemiasterlin analogs
#734Erk7 and erk8, novel diagnostic markers for cancer
#735Novel G protein-coupled receptor encoding gene and diagnostic uses therefor
#736Multiple marker assay for detection of ovarian cancer
#737Sim2 polypeptides and polynucleotides and uses of each in diagnosis and treatment of ovarian, breast and lung cancers
#738Braca1/acc alpha molecular complexes, diagnostic and therapeutic applications
#739Methods for diagnosis and prognosis of cancer
#740Eef1a2 for use in the prognosis, diagnosis, and treatment of cancer
#741Methods for detecting breast and ovarian cancer
#742Methods and compositions for diagnosing neoplastic disease
#743Compositions and methods for the therapy and diagnosis of ovarian cancer
#744Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
#745Methods of oligosaccharide profiling for the detection of cancer
#746Aberrant kallikrein expression
#747Methods and compositions for the detection of ovarian disease
#748Serpentine transmembrane antigens expressed in human cancers and uses thereof
#749Luminescence characterization of quantum dots conjugated with biomarkers for early cancer detection
#750Methods for detecting ovarian cancer
#751Methods and compositions for evaluation of fertility
#752Methods of detecting ovarian neoplasia
#753Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody
#754Neoepitope detection of disease using protein arrays
#755Antigen panels and methods of using the same
#756Identification of cancer protein biomarkers using proteomic techniques
#757Biomarkers for detecting ovarian cancer
#758Antibodies, including Fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use
#759Methods for identification, assessment, prevention, and therapy of cancer
#760Diagnosing and treating cancer
#761HADHs as modifiers of the p21 pathway and methods of use
#762Novel receptors
#763HADHs as modifiers of the p21 pathway and methods of use
#764Compositions and methods relating to ovary specific genes and proteins
#765Early detection of cancer of specific type using 1HNMR metabonomics
#766Chds as modifiers of the p53 pathway and methods of use
#767Methods for the early diagnosis of ovarian cancer
#768Method for manufacturing a layer lamination integrated fuel cell and the fuel cell itself
#769Novel method of diagnosing, monitoring, staging, imaging and treating various cancers
#770Novel method of diagnosing, monitoring, staging, imaging and treating various cancers
#771Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
#772Novel method for the detection of cancer biomarkers in cervical specimens
#773Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
#774Dgks as modifiers of the p53 pathwha and methods of use
#775Interleukin-8 homologous polypeptides and therapeutic uses thereof
#776Cytotoxicity mediation of cells evidencing surface expression of CD44
#777Methods of detecting cancer based on osteopontin
#778Multifactorial assay for cancer detection
#779JAB1 as a prognostic marker and a therapeutic target for human cancer
#780Use of biomarkers for detecting ovarian cancer
#781Methods for predicting pregnancy outcome in a subject by hCG assay
#782Cancerous disease modifying antibodies
#783Gene amplification and overexpression in cancer
#784Methods of detecting ovarian cancer based on osteopontin
#785Cytotoxicity mediation of cells evidencing surface expression of CD44
#786Serpentine transmembrane antigens expressed in human cancers and uses thereof
#787SHC proteins as therapeutic targets in proliferative diseases
#788Methods and systems for treating disease using an ATR/Chk1 signaling pathway inhibitor
#789Convolutional neural networks for cancer diagnosis
#790Micro-RNA profiling in ovarian cancer